全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2015 

mapks与keap1-nrf2-are信号通路的窜扰作用在慢性阻塞性肺疾病中的作用及意义

, PP. 133-140

Keywords: 慢性阻塞性肺疾病,有丝分裂素激活蛋白激酶类,核因子e2相关因子2

Full-Text   Cite this paper   Add to My Lib

Abstract:

慢性阻塞性肺疾病(chronicobstructivepulmonarydisease,copd)是一种可预防和治疗的疾病,与有害颗粒或气体对肺损伤有关,病理特征为气流受限、慢性呼吸道炎症,其主要病理表现为炎症反应、黏液分泌过量、氧化应激和上皮细胞凋亡。现代研究表明,mapks与keap1-nrf2-are信号通路参与调控炎症、氧化应激等病理过程。本文重点探讨以上信号通路在炎症反应、黏液分泌过量、氧化应激和上皮细胞凋亡中的相互影响,并在此基础上关注与mapks及keap1-nrf2-are信号通路相关的药物,以期阐明mapks和keap1-nrf2-are信号通路及其窜扰作用在调控copd病理生理中的重要作用和意义,同时为copd防治的药物研究和开发提供更多思路。

References

[1]  worldhealthorganization.theglobalburdenofdisease:2004update[r].geneva:who,2008.
[2]  murraycj,lopezad.alternativeprojectionsofmortalityanddisabilitybycause1990-2020:globalburdenofdiseasestudy[j].lancet,1997,349:1498-1504.
[3]  pandeyr,singhm,singhalu,etal.oxidative/nitrosativestressandthepathobiologyofchronicobstructivepulmonarydisease[j].jclindiagnres,2013,7:580-588.
[4]  leikaufgd,borchersmt,prowsdr,etal.mucinapoproteinexpressionincopd[j].chest,2002,121:166s-182s.
[5]  schmidtep,tuderrm.roleofapoptosisinamplifyinginflammatoryresponsesinlungdiseases[j].jcelldeath,2010,2010:41-53.
[6]  mercerba,d'armientojm.emergingroleofmapkinasepathwaysastherapeutictargetsincopd[j].intjchronobstructpulmondis,2006,1:137-150.
[7]  macneew.oxidants/antioxidantsandcopd[j].chest,2000,117:303-317.
[8]  bouttena,govend,artaud-macarie,etal.nrf2target-ing:apromisingtherapeuticstrategyinchronicobstructivepulmonarydisease[j].trendsmolmed,2011,17:363-371.
[9]  chungkf,marwickja.molecularmechanismsofoxida-tivestressinairwaysandlungswithreferencetoasthmaandchronicobstructivepulmonarydisease[j].annnyacadsci,2010,1203:85-91.
[10]  batailleam,manautouje.nrf2:apotentialtargetfornewtherapeuticsinliverdisease[j].clinpharmacolther,2012,92:340-348.
[11]  buistas,mcburniema,vollmerwm,etal.internationalvariationintheprevalenceofcopd(theboldstudy):apopulation-basedprevalencestudy[j].lancet,2007,370:741-750.
[12]  gershonas,warnerl,cascagnettep,etal.lifetimeriskofdevelopingchronicobstructivepulmonarydisease:alongitudinalpopulationstudy[j].lancet,2011,378:991-996.
[13]  mcdonoughje,yuanr,suzukim,etal.small-airwayobstructionandemphysemainchronicobstructivepulmonarydisease[j].nengljmed2011,365:1567-1575.
[14]  saettam,turatog,facchinifm,etal.inflammatorycellsinthebronchialglandsofsmokerswithchronicbronchitis[j].amjrespircritcaremed,1997,156:1633-1639.
[15]  repineje,basta,lankhorsti.oxidativestressinchronicobstructivepulmonarydisease[j].amjrespircritcaremed,1997,156:341-357.
[16]  macneew.oxidativestressandlunginflammationinairwaysdisease[j].eurjpharmacol,2001,429:195-207.
[17]  nebredaar,porrasa.p38mapkinases:beyondthestressresponse[j].trendsbiochemsci,2000,25:257-260.
[18]  manningam,davisrj.targetingjnkfortherapeuticbenefit:fromjunktogold?[j].natrevdrugdiscov,2003,2:554-565.
[19]  kyriakisjm,avruchj.mammalianmitogen-activatedproteinkinasesignaltransductionpathwaysactivatedbystressandinflammation[j].physiolrev,2001,81:807-869.
[20]  munshia,rameshr.mitogen-activatedproteinkinasesandtheirroleinradiationresponse[j].genescancer,2013,4:401-408.
[21]  morrisondk,davisrj.regulationofmapkinasesig-nalingmodulesbyscaffoldproteinsinmammals[j].annurevcelldevbiol,2003,19:91-118.
[22]  enslenh,davisrj.regulationofmapkinasesbydock-ingdomains[j].biolcell,2001,93:5-14.
[23]  itohk,chibat,takahashis,etal.annrf2/smallmafheterodimermediatestheinductionofphaseⅱdetoxifyingenzymegenesthroughantioxidantresponseelements[j].biochembiophysrescommun,1997,236:313-322.
[24]  vomhof-dekreyee,picklosrmj.thenrf2-antioxi-dantresponseelementpathway:atargetforregulatingenergymetabolism[j].jnutrbiochem,2012,23:1201-1206.
[25]  bairdl,swifts,llèresd,etal.monitoringkeap1-nrf2interactionsinsinglelivecells[j].biotechnoladv,2014,32:1133-1144.
[26]  hayashia,suzukih,itohk,etal.transcriptionfactornrf2isrequiredfortheconstitutiveandinducibleexpressionofmultidrugresistance-associatedprotein1inmouseembryofibroblasts[j].biochembiophysrescommun,2003,310:824-829.
[27]  okadak,shodaj,taguchik,etal.ursodeoxycholicacidstimulatesnrf2-mediatedhepatocellulartransport,detoxification,andantioxidativestresssystemsinmice[j].amjphysiolgastrointestliverphysiol,2008,295:g735-g747.
[28]  gann,mil,sunx,etal.sulforaphaneprotectsmicro-cystin-lr-inducedtoxicitythroughactivationofthenrf2-mediateddefensiveresponse[j].toxicolapplpharmacol,2010,247:129-137.
[29]  hunleej,shul,fuentesf,etal.cancerchemopreven-tionbytraditionalchineseherbalmedicineanddietaryphytochemicals:targetingnrf2-mediatedoxidativestress/anti-inflammatoryresponses,epigenetics,andcancerstemcells[j].jtraditcomplementmed,2013,3:69-79.
[30]  malhotrad,thimmulappark,mercadon,etal.denitrosylationofhdac2bytargetingnrf2restoresglucocorticosteroidsensitivityinmacrophagesfromcopdpatients[j].jclininvest,2011,121:4289-4302.
[31]  ishiiy,itohk,morishimay,etal.transcriptionfactornrf2playsapivotalroleinprotectionagainstelastase-inducedpulmonaryinflammationandemphysema[j].jimmunol,2005,175:6968-6975.
[32]  iizukat,ishiiy,itohk,etal.nrf2-deficientmicearehighlysusceptibletocigarettesmoke-inducedemphysema[j].genescells,2005,10:1113-1125.
[33]  cullinansb,gordanjd,jinj,etal.thekeap1-btbproteinisanadaptorthatbridgesnrf2toacul3-basede3ligase:oxidativestresssensingbyacul3-keap1ligase[j].molcellbiol,2004,24:8477-8486.
[34]  levys,jaiswalak,formanhj.theroleofc-junphosphorylationinepreactivationofphaseⅱgenes[j].freeradicbiolmed,2009,47:1172-1179.
[35]  rothm.pathogenesisofcopd.partⅱi.inflammationincopd[j].intjtuberclungdis,2008,12:375-380.
[36]  spiesspc,kasaharad,habibovica,etal.acroleinexpo-suresuppressesantigen-inducedpulmonaryinflammation[j].respirres,2013.doi:10.1186/1465-9921-14-107.
[37]  hristovam,spiesspc,kasaharadi,etal.thetobaccosmokecomponent,acrolein,suppressesinnatemacrophageresponsesbydirectalkylationofc-junn-terminalkinase[j].amjrespircellmolbiol,2012,46:23-33.
[38]  zhoux,angy,chenjc.inhibitoryeffectsofhydrogensulphideonpulmonaryfibrosisinsmokingratsviaattenuationofoxidativestressandinflammation[j].jcellmolmed,2014,18:1098-1103.
[39]  parksj,leeks,leesj,etal.l-2-oxothiazolidine-4-carboxylicacidorα-lipoicacidattenuatesairwayremodeling:involvementofnuclearfactor-κb(nf-κb),nuclearfactorerythroid2p45-relatedfactor-2(nrf2),andhypoxia-induciblefactor(hif)[j].intjmolsci,2012,13:7915-7937.
[40]  hsucl,wuyl,tanggj,etal.ginkgobilobaextractconfersprotectionfromcigarettesmokeextract-inducedapoptosisinhumanlungendothelialcells:roleofhemeoxygenase-1[j].pulmpharmacolther,2009,22:286-296.
[41]  kweonmh,adhamivm,leejs,etal.constitutiveoverexpressionofnrf2-dependenthemeoxygenase-1ina549cellscontributestoresistancetoapoptosisinducedbyepigallocatechin3-gallate[j].jbiolchem,2006,281:33761-33772.
[42]  papaiahgaris,zhangq,kleebergersr,etal.hyperoxiastimulatesannrf2-aretranscriptionalresponseviaros-egfr-pi3k-akt/erkmapkinasesignalinginpulmonaryepithelialcells[j].antioxidredoxsignal,2006,8:43-52.
[43]  chohy,gladwellw,yamamotom,etal.exacerbatedairwaytoxicityofenvironmentaloxidantozoneinmicedeficientinnrf2[j].oxidmedcelllongev,2013.doi:10.1155/2013/254069
[44]  yagetay,ishiiy,morishimay,etal.carbocisteinere-ducesvirus-inducedpulmonaryinflammationinmiceexposedtocigarettesmoke[j].amjrespircellmolbiol,2014,50:963-973.
[45]  yuh,liq,kolosovvp,perelmanjm,etal.regulationofcigarettesmoke-inducedmucinexpressionbyneuregulin1β/erbb3signallinginhumanairwayepithelialcells[j].basicclinpharmacoltoxicol,2011,109:63-72.
[46]  wangy,sheny,lik,etal.roleofmatrixmetallopro-teinase-9inlipopolysaccharide-inducedmucinproductioninhumanairwayepithelialcells[j].archbiochembiophys,2009,486:111-118.
[47]  macneew.pulmonaryandsystemicoxidant/antioxidantimbalanceinchronicobstructivepulmonarydisease[j].procamthoracsoc,2005,2:50-60.
[48]  macneew.pathogenesisofchronicobstructivepulmo-narydisease[j].clinchestmed,2007,28:479-513.
[49]  macneew,rahmani.isoxidativestresscentraltothepathogenesisofchronicobstructivepulmonarydisease?[j].trendsmolmed,2001,7:55-62.
[50]  chengse,leeit,lincc,etal.cigarettesmokeparticle-phaseextractinducesho-1expressioninhumantrachealsmoothmusclecells:roleofthec-src/nadphoxi-dase/mapk/nrf2signalingpathway[j].freeradicbiolmed,2010,48:1410-1422.
[51]  govend,bouttena,leçon-malasv,etal.prolongedcigarettesmokeexposuredecreaseshemeoxygenase-1andaltersnrf2andbach1expressioninhumanmacrophages:rolesofthemapkinaseserk1/2andjnk[j].febslett,2009,583:3508-3518.
[52]  ryumj,kangka,piaomj,etal.effectof7,8-dihydroxy-flavoneontheup-regulationofnrf2-mediatedhemeoxygenase-1expressioninhamsterlungfibroblasts[j].invitrocelldevbiolanim,2014,50:549-554.
[53]  decosterda,jonesm.tailoringofcorticosteroidsincopdmanagement[j].currrespircarerep,2014,3:121-132.
[54]  lomasda,lipsonda,millerbe,etal.anoralinhibitorofp38mapkinasereducesplasmafibrinogeninpatientswithchronicobstructivepulmonarydisease[j].jclinpharmacol,2012,52:416-424.
[55]  chungkf.p38mitogen-activatedproteinkinasepathwaysinasthmaandcopd[j].chest,2011,139:1470-1479.
[56]  singhd,smythl,borrillz,etal.arandomized,placebo-controlledstudyoftheeffectsofthep38mapkinhibitorsb-681323onbloodbiomarkersofinflammationincopdpatients[j].jclinpharmacol,2010,50:94-100.
[57]  sadowskaam,luytenc,vintsam,etal.systemicantioxidantdefencesduringacuteexacerbationofchronicobstructivepulmonarydisease[j].respirology,2006,11:741-747.
[58]  bridgemanmm,marsdenm,selbyc,etal.effectofn-acetylcysteineontheconcentrationsofthiolsinplasma,bronchoalveolarlavagefluid,andlungtissue[j].thorax,1994,49:670-675.
[59]  tsehn,raiteril,wongky,etal.benefitsofhighdosen-acetylcysteinetoexacerbation-pronecopdpatients[j].chest,2014,146:611-623.
[60]  messierem,daybj,bahmedk,etal.n-acetylcysteineprotectsmurinealveolartypeⅱcellsfromcigarettesmokeinjuryinanuclearerythroid2-relatedfactor-2-independentmanner[j].amjrespircellmolbiol,2013,48:559-567.
[61]  yasudah,yamayam,sasakit,etal.carbocisteinere-ducesfrequencyofcommoncoldsandexacerbationsinpa-tientswithchronicobstructivepulmonarydisease[j].jamgeriatrsoc,2006,54:378-380.
[62]  liyp.resveratrolattenuatesendoplasmicreticulumstressandalveolarepithelialapoptosisincopdrats(白藜芦醇减轻copd内质网应激诱导的肺泡上皮细胞凋亡研究)[d].changsha:centralsouthuniversity,2013.
[63]  vandivierrw,hensonpm,douglasis.buryingthedead:theimpactoffailedapoptoticcellremoval(efferocytosis)onchronicinflammatorylungdisease[j].chest,2006,129:1673-1682.
[64]  sabiog,davisrj.tnfandmapkinasesignalingpathways[j].seminimmunol,2014,26:237-245.
[65]  schievengl.thep38αkinaseacentralroleininflamma-tion[j].currtopmedchem,2009,9:1038-1048.
[66]  masarusi,tomokob,yokoi,etal.down-regulatednf-e2-relatedfactor2inpulmonarymacrophagesofagedsmokersandpatientswithchronicobstructivepulmonarydisease[j].amjrespircellmolbiol,2008,39:673-682.
[67]  maq,battellil,hubbsaf.multiorganautoimmuneinflammation,enhancedlymphoproliferation,andimpairedhomeostasisofreactiveoxygenspeciesinmicelackingtheantioxidant-activatedtranscriptionfactornrf2[j].amjpathol,2006,168:1960-1974.
[68]  jainak,bloomda,jaiswalak.nuclearimportandexportsignalsincontrolofnrf2[j].jbiolchem,2005,280:29158-29168.
[69]  osburnwo,wakabayashin,misrav,etal.nrf2regu-latesanadaptiveresponseprotectingagainstoxidativedamagefollowingdiquat-mediatedformationofsuperoxideanion[j].archbiochembiophys,2006,454:7-15.
[70]  mccartymf.polyphenol-mediatedinhibitionofap-1transactivatingactivitymayslowcancergrowthbyimpedingangiogenesisandtumorinvasiveness[j].medhypotheses,1998,50:511-514.
[71]  sunz,huangz,zhangdd.phosphorylationofnrf2atmultiplesitesbymapkinaseshasalimitedcontributioninmodulatingthenrf2-dependentantioxidantresponse[j].plosone,2009.doi:10.1371/journal.pone.0006588.
[72]  yur,chenc,moyy,etal.activationofmito-gen-activatedproteinkinasepathwaysinducesantioxidantresponseelement-mediatedgeneexpressionviaanrf2-dependentmechanism[j].jbiolchem,2000,275:39907-39913.
[73]  hayesjd,ellisem,nealge,etal.cellularresponsetocancerchemopreventiveagents:contributionoftheantioxidantresponsiveelementtotheadaptiveresponsetooxidativeandchemicalstress[j].biochemsocsymp,1999,64:141-168.
[74]  leed,baej,kimyk,etal.inhibitoryeffectsofberber-ineonlipopolysaccharide-inducedinduciblenitricoxidesynthaseandthehigh-mobilitygroupbox1releaseinmacrophages[j].biochembiophysrescommun,2013,431:506-511.
[75]  wangy.attenuationofberberineonlipopolysaccharide-inducedinlammatoryandapoptosisresponsesinβ-cellsviatlr4-independentjnk/nf-κbpathway[j].pharmbiol,2014,52:532-538.
[76]  macneew,allanrj,jonesi,etal.efficacyandsafetyoftheoralp38inhibitorph-797804inchronicobstructivepulmonarydisease:arandomisedclinicaltrial[j].thorax,2013,68:738-745.
[77]  banerjeea,koziol-whitec,panettierirjr.p38mapkinhibitorsikk2inhibitors,andtnfαinhibitorsincopd[j].curropinpharmacol,2012,12:287-292.
[78]  millands,bunnageme,burrowsjl,etal.designandsynthesisofinhaledp38inhibitorsforthetreatmentofchronicobstructivepulmonarydisease[j].jmedchem,2011,54:7797-7814.
[79]  ratcliffemj,dougallig.comparisonoftheanti-inflam-matoryeffectsofcilomilast,budesonideandap38mitogenactivatedproteinkinaseinhibitorincopdlungtissuemacrophages[j].bmcpharmacoltoxicol,2012.doi:10.1186/2050-6511-13-15.
[80]  rahmani,macneew.antioxidantpharmacologicaltherapiesforcopd[j].curropinpharmacol,2012,12:256-265.
[81]  harveycj,thimmulappark,sethis,etal.targetingnrf2signalingimprovesbacterialclearancebyalveolarmacrophagesinpatientswithcopdandinamousemodel[j].scitranslmed,2011,3:78ra32.doi:10.1126/scitranslmed.3002042.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133